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The Development of Contraceptive Methods 
for Captive Wildlife 
Cheryl S. Asa 
Abstract: Contraception has become critical in managing 
zoo populations, both to limit production of surplus animals 
and to promote genetic health. One role of the 
Contraception Advisory Group, formed in 1989, is to 
coordinate research to develop new contraceptive methods. 
Because melengestrol acetate (MGA) implants, which have 
been used by zoos for almost 20 years, recently have been 
associated with uterine pathology in felids, several new 
contraceptive techniques are being evaluated. These 
include other steroid hormone formulations, such as the 
birth control pill Depo-Provers,@ the Norplanm implant, and 
MGA added to feed; bisdiamine, an oral male contraceptive; 
zona pellucida (ZP) vaccine; and vas plugs. Bisdiamine 
reversibly blocked spermatogenesis while sparing 
testosterone in its first test in gray wolves. ZP vaccine has 
Introduction 
The modern zoo now faces the consequences of 
becoming too successful at breeding and maintaining 
the animals in its care. Advances in husbandry, 
nutrition, and medicine have resulted in more births 
and longer lives for most captive species. The major 
benefit of this success is that these captive popula- 
tions can be self-perpetuating and not dependent on 
importation of animals from the wild. However, due to 
limited space and resources, zoos cannot allow 
uncontrolled reproduction. 
In addition, zoos give high priority to proper 
genetic management, that is, reduction of inbreeding 
and balanced genetic representation of the founders 
of captive populations. Both genetic management and 
limiting production of surplus animals are being 
accomplished through contraception. 
Although physical separation of males and 
females can prevent unwanted conceptions, most 
zoos consider this an undesirable measure. Not only 
can such an arrangement be stressful for species in 
which males and females typically associate, lone 
animals present an unnatural view of that species to 
the visiting public. A primary mission of zoos is 
education, a mission that is better served by maintain- 
ing animals in social groupings which are as represen- 
tative as possible of the organization that would occur 
in the wild. 
been effective in preventing births in a variety of species of 
hoofstock, primates, and carnivores; however, long-term 
deleterious effects on the ovaries have been found in some 
controlled trials. Injectable vas plugs that conform to the 
shape of the vas make it possible to successfully treat a 
wide variety of species; reversal trials are currently 
underwav. As research efforts continue, we hODe to ex~and 
our collaborations with scientists working on contracepiive 
devel0Dment for humans. com~anion animals and wildlife. 
to better make use of the limited resources available for 
these investigations. 
Keywords: contraception, captive animals, zoo, vas plugs, 
bisdiamine, indenopyridine, zona pellucida vaccine, GnRH 
agonist, LHRH vaccine 
In recognition of the importance of contraception 
in responsible animal management, the American 
Association of Zoos and Aquariums approved forma- 
tion of the Contraception Advisory Group in 1989. 
Composed of zoo curators, veterinarians, and repro- 
ductive physiologists, the group surveys the use of 
contraception in zoos for inclusion in a computerized 
data base, advises zoo personnel, and initiates and 
coordinates research into alternative methods. 
The International Wildlife Contraception Data- 
base, housed at the St. Louis Zoo, was developed and 
is maintained by Ingrid Porton and Betsy Hornbeck of 
the Contraception Advisory Group. Begun in 1990 
and updated from yearly surveys, it currently contains 
more than 2,000 complete records on 184 species and 
serves as a resource for zoo animal managers and for 
researchers. 
Contraception of captive wildlife in zoos began in 
the mid-1970's. After preliminary tests with lions and 
tigers (Seal et al. 1976, Seal and Plotka 1978) com- 
paring medroxyprogesterone acetate (Provera,BThe 
Upjohn Co., Kalamazoo, MI, USA) and melengestrol 
acetate (MGA, also Upjohn), MGA in silicone implant 
form was selected as the more suitable. Of the more 
than 80 percent of North American zoos that reported 
using contraception (Porton et al. 1990), most use the 
MGA implant. 
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However, concern has arisen about possible 
pathology in progestin-treated carnivores (Kollias 
1988, Kollias et al. 1984) because deleterious effects 
have been associated with progestin use in domestic 
dogs and cats (reviewed in Asa and Porton 1991, Asa 
et al. 1996). Indeed, histological examination of uteri 
from MGA-treated felids has revealed significantly 
more pathology than those from untreated felids 
(Munson and Mason 1991). 
No comparable effects are expected in primates, 
based on the extensive studies that have been con- 
ducted in laboratory primates, as well as decades of 
progestin administration to human females. In gen- 
eral, birth control methods that have been approved 
for human use should be safe and effective for nonhu- 
man primates. Birth control pills (combination proges- 
tin and estrogen, various formulations commercially 
available), Depo-Provera, Norplant (levonorgestrel 
implant system, Wyeth-Ayerst, Philadelphia, PA, 
USA), and intrauterine devices have been used in 
primates, especially in the great apes (Porton et al. 
1990). However, few data exist on progestin effects in 
ungulates and other mammals. 
A number of research trials are under way to 
evaluate new approaches with the hope of providing a 
broader selection of contraceptives, especially alterna- 
tives to the progestin-based formulations for carnivores. 
These include vas plugs, the antispermatogenic com- 
pounds bisdiamine and indenopyridine, and short-term 
Depo-Provera for seasonal breeders. Additional work is 
focusing on specific aspects of MGA treatment. For a 
discussion of the progress of zona pellucida trials in 
zoos, see Kirkpatrick et al., this volume. 
Melengestrol Acetate 
As mentioned, MGA is the most frequently used 
contraceptive for captive mammals. MGA is incorpo- 
rated into silicone rods by E. D. Plotka (Marshfield 
Medical Research Foundation, Marshfield, WI) and 
distributed to zoos throughout the world. When 
inserted subcutaneously, the implants provide effec- 
tive contraception for at least 2 years (Porton et al. 
1990). The only side effect noted in primates has 
been weight gain (Portugal and Asa 1995), which is 
also common in human females treated with 
progestins. 
Because of concern about possible effects on 
social behavior, a study was conducted with a troop of 
hamadryas baboons (Papio hamadryas) at the St. 
Louis Zoo (Portugal and Asa 1995). Administration of 
MGA was not associated with social disruption. 
Treated females were involved in fewer affiliative 
interactions, but there was no increase in aggression 
compared to control animals. 
Although MGA implants have been effective in a 
wide range of monkeys and apes, some New World 
primate species have proven resistant. Because they 
have naturally high levels of endogenous steroids, 
these species may require larger exogenous doses to 
achieve contraception. Research is being conducted 
to test this hypothesis (E. Plotka, pers. comm.). 
Recognizing that individual capture and immobili- 
zation for implant insertion may be inadvisable in 
some situations, Bronx Zoo veterinarians (B. Raphael, 
pers. comm.) have tested adding MGA to feed for 
herds of antelope and deer. Although this procedure 
is generally successful, drawbacks include contracep- 
tive failure in some subordinate animals that appar- 
ently did not ingest a sufficient dose and alteration of 
the antler cycle in male barasinga (Cervus duvauceli). 
Pathological effects of MGA and related 
progestins are being investigated by Linda Munson 
(University of Tennessee, Knoxville). Early work 
concentrated on reproductive tracts of felids (Munson 
and Mason 1991), and research is now extending to 
other carnivores and primates. In general, progestins 
have been found to stimulate growth of the uterine 
lining of felids and canids, resulting in hyperplasia, 
pyometra, and neoplasia (reviewed in Asa and Porton 
1991). Effects of dosage, length of treatment, and age 
during treatment are currently being studied. 
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Depo-Provera 
The belief that side effects can be minimized by a 
shorter treatment period has created interest in the 
progestin medroxyprogesterone acetate in its inject- 
able, slow-release formulation. In particular, seasonal 
breeders that are fertile for only part of the year might 
benefit from progestin exposure for only that period, 
as opposed to the continual, long-term exposure 
imposed by an implant. An injection every 2-3 months 
is thought to be preferable to the repeated surgical 
procedures required for implant insertion and removal. 
Doselresponse trials and evaluation of weight 
gain have been conducted with ruffed lemurs (Varecia 
variegata) and black lemurs (L. macaco) at the St. 
Louis Zoo, in collaboration with the Henson-Robinson 
and Metro Toronto zoos. Using vaginal cytology to 
monitor suppression of cycles, researchers found the 
minimum effective dose to be 5 mg per kilogram of 
body weight. Pelage darkening in treated black lemur 
females was an unexpected side effect, probably 
related to the ability of this progestin to bind androgen 
receptors (Labrie et al. 1987). (Black lemurs are 
sexually dimorphic in color, with males having a black 
and females a brown coat). 
Depo-Provera also is being used in hippopota- 
muses (Choeropsis liberiensis), giraffes (Giraffa 
camelopardus), sea lions (Zalophus californianus), 
and gray seals (Halichoerus grypus), although not part 
of controlled research projects. There is concern 
about sea lions and seals, in particular, because they 
are closely related to the carnivores and because they 
have extensive fat stores that may absorb and hold 
steroids, which are lipophilic. Fat stores may also 
present a problem with hippos. 
Norplant 
Although no controlled studies have been published, 
several zoos are using these implants, which contain 
levonorgestrel, a synthetic progestin related to both 
MGA and Provera. Its advantage over MGA is the 
much thinner capsules, which can be inserted with a 
trocar. Com~ared to the incision and sutures needed 
for the MGA implants, the small puncture site attracts 
less grooming and reduces the chance of loss. 
Birth Control Pills 
As with Norplant, some zoos opt to use oral birth 
control pills, another product developed for the human 
market. The willingness of many apes to take pills 
placed in food treats dispenses with the need for 
immobilization and insertion of an implant. The vast 
majority of pills contain estrogen in combination with a 
much lower dose of progestin than is present in the 
progestin-only forms discussed above. Although this 
combination does not significantly alter the associated 
side effects for primates, it is not appropriate for 
carnivores. Adding estrogen to progestin in formula- 
tions given to dogs exacerbates uterine pathology 
(Teunissen 1952). 
Megestrol Acetate 
Another synthetic progestin-available as MegaceB 
(Mead Johnson Laboratories, Evansville, IN, USA) or 
OvabanB (Schering-Plough, Union, NJ, USA)-is 
sometimes used as a contraceptive in domestic dogs 
and cats. However, because of the attendant risk of 
hyperplasia and pyometra, this synthetic it is not 
recommended for more than two consecutive treat- 
ments. 
Lupron Depot@ 
An agonist of GnRH (gonadotropin-releasing hormone 
also called LHRH, luteinizing-hormone releasing 
hormone), Lupron Depot (TAP Pharmaceuticals, North 
Chicago, IL, USA) has been used in males of several 
species in attempts to block spermatogenesis. Although 
theoretically tenable, this approach has been unsuc- 
cessful due to incomplete suppression of sperm 
production. Sperm numbers must be reduced below 
the level required for fertilization for this to be an 
effective contraceptive. Because the GnRH agonists 
and antagonists block production of testosterone, they 
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also can find application in suppression of aggression 
in some individuals. 
Lupron Depot also has been given to females to 
suppress cyclicity. However, because agonists first 
stimulate the endocrine cascade that results in ovula- 
tion, administration to induced ovulators, such as the 
felids, may stimulate ovulation and pseudopregnancy 
before suppressing cycles by negative feedback. 
Although analogues show promise in providing 
the equivalent of reversible chemical castrations, their 
current cost prohibits for widespread use. Long-term 
delivery also is a problem. Because these compounds 
are not orally active and do not follow the same 
diffusion dynamics as steroids, traditional delivery 
methods such as silicone implants have not been 
effective. Both a silicone elastomer matrix and a 
reservoir system are being tested (Vickery et al. 
1989). 
LHRH Vaccine 
Immunization against LHRH can provide contraception 
for both males and females (Fraser 1986). LHRH 
initiates the cascade of hormonal events that results in 
testosterone and sperm production in males and in 
production of estrogen and progesterone and ovula- 
tion in females. Because this vaccination would 
accomplish the equivalent of a reversible chemical 
castration, it can be especially appropriate for males 
to suppress testosterone and thus aggression and for 
female carnivores to completely suppress secretion of 
progesterone. Vaxstrate, an LHRH vaccine that is 
commercially available in Australia (Arthur Webster 
Pty. Ltd., New South Wales, Australia) for domestic 
cows (Hoskinson et al. 1990), has also been used with 
success in some exotic species at the Western Plains 
and Perth zoos (D. Blyde and S. Haigh, pers. comm.). 
In this country, both The Population Council in New 
York and Colorado State University are developing 
LHRH vaccines. 
Bisdiamine 
All the steroid hormone preparations in use in zoos 
target the female. However, if prevention of reproduc- 
tion is desired in polygynous social groups, it is more 
efficient to treat the males than the females. The 
bisdiamine WIN 18,446 (Sterling Winthrop, 
Rensselaer, NY, USA) was tested in the early 1960's 
as a birth control pill for men. It works by selectively 
interfering with spermatogenesis but not testosterone 
production. Although initial trials demonstrated the 
drug to be effective, safe, and reversible, it was soon 
discovered to interact with an enzyme that detoxifies 
alcohol. Thus, men taking bisdiamine who then drank 
alcohol became ill, making the compound unsuitable 
for general marketing. Because we assume that we 
can prevent alcohol consumption in captive animals, 
bisdiamine may be a feasible contraceptive alternative 
for this application. 
The first test of bisdiamine in a wildlife species 
was conducted with a captive colony of gray wolves 
(Asa et al. 1995). Daily administration in ground meat 
at a dose of 200 mglkg suppressed spermatogenesis 
without affecting mating behavior. In the subsequent 
breeding season, semen samples of the previously 
treated males were comparable to those of controls, 
confirming reversibility. 
lndenopyridine 
This drug (Research Triangle Institute, Research 
Triangle Park, NC, USA) is similar to bisdiamine in 
that it is orally active and blocks sperm production 
without interrupting testosterone secretion. To date, it 
has been tested only in rodents (Fail et al. 1991, 
Gurtler and Donatsch 1979, Hodel and Suter 1978), 
so the extent of its efficacy and safety has not been 
adequately determined. A dose response trial with 
domestic cats, as a model for exotic felids, is currently 
being conducted (Fail et al., unpubl.) 
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Vas Plugs 
L.J.D. Zaneveld and I investigated vas plugs. Silicone 
injected into the vas deferens, the tube carrying sperm 
from the testis, hardens to form a barrier that prevents 
the passage of sperm. Plugs were placed in 59 
mammals, including marsupials, felids, primates, and 
ungulates, at 17 different zoos. Early use of the 
preformed plug (Zaneveld et al. 1988), which is also in 
clinical trials with humans, proved inadequate for the 
range of vas sizes encountered in zoo animals. The 
injectable plugs were successful in blocking passage 
of sperm, but fertility was not restored after removal. 
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